Auteurs
Analysis
Canada
Racine
Analysis
Canada
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie - Analysis (Canada)

Index « Auteurs » - entrée « Lari Wenzel »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Lara Sucheston-Campbell < Lari Wenzel < Larisa Apov  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 1.
Ident.Authors (with country if any)Title
000C87 (2014) Martin R. Stockler [Australie] ; Felix Hilpert [Allemagne] ; Michael Friedlander [Australie] ; Madeleine T. King [Australie] ; Lari Wenzel [Canada] ; CHEE KHOON LEE [Australie] ; Florence Joly [France] ; Nikolaus De Gregorio [Allemagne] ; José Angel Arranz [Espagne] ; Mansoor Raza Mirza [Danemark] ; Roberto Sorio [Italie] ; Ulrich Freudensprung [Suisse] ; Vesna Sneller [Australie] ; Gill Hales [Australie] ; Eric Pujade-Lauraine [France]Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

List of associated KwdEn.i

Nombre de
documents		Descripteur
1Adult
1Aged
1Aged, 80 and over
1Antiangiogenic agent
1Antibodies, Monoclonal, Humanized (administration & dosage)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (adverse effects)
1Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
1Antineoplastic agent
1Bevacizumab
1Cancerology
1Chemotherapy
1Doxorubicin (administration & dosage)
1Doxorubicin (adverse effects)
1Doxorubicin (analogs & derivatives)
1Doxorubicin (therapeutic use)
1Drug Administration Schedule
1Drug Resistance, Neoplasm
1Evolution
1Female
1Human
1Humans
1Immunomodulator
1Middle Aged
1Organoplatinum Compounds (pharmacology)
1Ovarian Neoplasms (drug therapy)
1Ovary cancer
1Paclitaxel (administration & dosage)
1Paclitaxel (adverse effects)
1Paclitaxel (therapeutic use)
1Phase III trial
1Platinum
1Polyethylene Glycols (administration & dosage)
1Polyethylene Glycols (adverse effects)
1Polyethylene Glycols (therapeutic use)
1Prognosis
1Self Report
1Topotecan (administration & dosage)
1Topotecan (adverse effects)
1Topotecan (therapeutic use)
1Treatment Outcome
1Treatment resistance
1Vascular endothelium growth factor

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Canada/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Lari Wenzel" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Lari Wenzel" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Lari Wenzel
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024